MedCap

366.5

SEK

+2.52 %

Less than 1K followers

MCAP

NASDAQ Stockholm

Investment

Financials

Overview

Financials & Estimates

Ownership

+2.52%

-8.38%

-39.02%

-38.4%

-25.05%

-4.56%

+126.51%

+110.39%

+3,528.71%

MedCap operates in the investment industry and focuses on long-term equity investments in medical technology and pharmaceutical companies. The company's portfolio includes companies in sectors such as biotechnology and medical technology. The operations are primarily concentrated in Sweden, with a primary presence in the Stockholm region. MedCap was founded in 2003 and is headquartered in Sweden.

Market cap

5.49B SEK

Turnover

1.15M SEK

Revenue

1.81B

EBIT %

15.07 %

P/E

26.18

Dividend yield-%

-

Financial calendar

29.4

2025

Interim report Q1'25

5.5

2025

General meeting '25

23.7

2025

Interim report Q2'25

ShowingAll content types

Press release2/3/2025, 7:53 AM

Redeye: MedCap Q4 2024 - A tale of euphoria and despair

Regulatory press release1/31/2025, 5:30 AM

MedCap AB: Good demand but unsatisfactory earnings. Strong cash flow.

Regulatory press release1/31/2025, 5:30 AM

MedCap AB: MedCap's Business Area Assistive Tech Acquires Danrehab

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account

Followings and notifications on followed companies

Analyst comments and recommendations

Stock comparison tool & other popular tools

Regulatory press release1/16/2025, 5:30 PM

MedCap AB: Preliminary result for the fourth quarter

Press release11/4/2024, 9:24 AM

Redeye: Redeye Initiates Coverage of MedCap

Regulatory press release10/25/2024, 4:30 AM

MedCap AB: Profit growth, stronger cash flow and acquisitions

Regulatory press release7/24/2024, 4:30 AM

MedCap AB: Continued strong growth - adjusted EBITA increased by 13 percent

Regulatory press release7/24/2024, 4:30 AM

MedCap AB: Abilia acquires Picomed and Alert-IT

Press release7/12/2024, 8:00 AM

MedCap AB: Changed date for the release of MedCap's half-year report 2024

Regulatory press release5/3/2024, 4:30 AM

MedCap AB: Strong first quarter - EBITA up 46 percent

Press release3/25/2024, 2:45 PM

MedCap AB: Abilia acquires Kompany AS and the product Komp

Regulatory press release1/31/2024, 5:30 AM

MedCap AB: Continued strong growth in the quarter - EBITDA increased by 42 percent

Regulatory press release10/27/2023, 4:30 AM

MedCap AB: Continued strong growth in the quarter - EBITDA increased by 63 percent

Regulatory press release10/26/2023, 2:15 PM

MedCap AB: MedCap acquires Swedelift

Regulatory press release7/28/2023, 4:30 AM

MedCap AB: Continued strong growth - EBITDA increased by 46 percent

Regulatory press release7/24/2023, 12:30 PM

MedCap AB: MedCap acquires SurgiCube and Toul Meditech

Regulatory press release5/3/2023, 4:30 AM

MedCap AB: Strong growth in the first quarter - adjusted EBITDA up 33 percent

Regulatory press release2/10/2023, 5:30 AM

MedCap AB: Strong organic growth in both the quarter and the year

Regulatory press release1/10/2023, 1:30 PM

MedCap AB (publ) announces the final outcome in its recommended cash offer to the shareholders of AdderaCare

Regulatory press release12/27/2022, 1:30 PM

MedCap AB: MedCap announces the final outcome in its recommended cash offer to the shareholders of AdderaCare

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.